Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On
June 15, 2018
AstraZeneca presented the results of a Russian study on the bioequivalence of fixed and free dapagliflozin
June 13, 2017
Compaction in the mammary gland. Treatment-diagnostic algorithm.
Atrial fibrillation. Choice of anticoagulant.
Anticoagulants in patients after knee transplantation
The choice of a drug for cough treatment in ARI of various etiologies
Anemia. Differential diagnosis
Aspirin in primary prevention of cardiovascular diseases
Pregnancy and type I diabetes mellitus: management tactics